Affiliation:
1. From the Harvard Medical School and Massachusetts General Hospital, Boston, MA
Abstract
Cost-effectiveness analysis (CEA) is an analytic tool that provides a framework for comparing the health benefits and resource expenditures associated with competing medical and public health interventions, thereby allowing decision makers to identify interventions that yield the greatest amount of health, given their resource constraints. Models are important components of most, if not all, CEAs, and they play a key role in evaluating the cost-effectiveness of cancer screening programs, in particular. In this article, we describe the basic types of models used to evaluate cancer screening programs and provide examples of the use of models in CEAs and to guide cancer screening policy. Finally, we offer some suggestions for important concepts to consider when interpreting model results.
Publisher
American Society of Clinical Oncology (ASCO)
Reference73 articles.
1. American Cancer Society: Cancer Facts and Figures 2006. Atlanta, GA, American Cancer Society, 2006
2. The Impact of Alternative Practices on the Cost and Quality of Mammographic Screening in the United States
3. National Health Spending In 2004: Recent Slowdown Led By Prescription Drug Spending
4. Heffler S, Smith S, Keehan S, et al: U.S. health spending projections for 2004-2014. Health Aff (Millwood) :W5-74,2005-W5-85, (suppl web exclusives)
5. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献